X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37) 37
female (35) 35
male (31) 31
middle aged (29) 29
adult (26) 26
hematology (25) 25
index medicus (23) 23
aged (21) 21
chemotherapy (21) 21
treatment outcome (15) 15
adolescent (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
lymphomas (14) 14
follow-up studies (13) 13
non-hodgkins-lymphoma (13) 13
combined modality therapy (12) 12
oncology (12) 12
disease-free survival (11) 11
life sciences (11) 11
rituximab (11) 11
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
cancer (10) 10
survival rate (9) 9
therapy (9) 9
abridged index medicus (8) 8
aged, 80 and over (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
cyclophosphamide (8) 8
immunology (8) 8
radiotherapy (8) 8
remission induction (8) 8
care and treatment (7) 7
cyclophosphamide - administration & dosage (7) 7
doxorubicin - administration & dosage (7) 7
doxorubicin - adverse effects (7) 7
doxorubicin - therapeutic use (7) 7
lymphoma (7) 7
b-cell lymphoma (6) 6
bone-marrow-transplantation (6) 6
hodgkin disease - drug therapy (6) 6
neoplasm staging (6) 6
prednisone - administration & dosage (6) 6
prospective studies (6) 6
survival analysis (6) 6
transplantation, autologous (6) 6
vincristine - administration & dosage (6) 6
antineoplastic agents - therapeutic use (5) 5
clinical trials (5) 5
disease (5) 5
doxorubicin (5) 5
hemic and lymphatic diseases (5) 5
hodgkin disease - radiotherapy (5) 5
hodgkin lymphoma (5) 5
lymphoma, follicular - drug therapy (5) 5
lymphoma, non-hodgkin - pathology (5) 5
recurrence (5) 5
retrospective studies (5) 5
time factors (5) 5
transplantation (5) 5
trial (5) 5
vincristine (5) 5
vincristine - therapeutic use (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
anthracyclines (4) 4
antibodies, monoclonal - administration & dosage (4) 4
bleomycin - administration & dosage (4) 4
bleomycin - adverse effects (4) 4
dacarbazine - administration & dosage (4) 4
dacarbazine - adverse effects (4) 4
dacarbazine - therapeutic use (4) 4
elderly-patients (4) 4
hematology, oncology and palliative medicine (4) 4
hodgkin's disease (4) 4
interferon (4) 4
irradiation (4) 4
lymphoma, follicular - mortality (4) 4
lymphoma, non-hodgkin - drug therapy (4) 4
methotrexate - administration & dosage (4) 4
non-hodgkins-lymphomas (4) 4
prednisone (4) 4
prednisone - adverse effects (4) 4
prednisone - therapeutic use (4) 4
primary cns lymphoma (4) 4
prognosis (4) 4
radiation-therapy (4) 4
regimen (4) 4
risk (4) 4
risk factors (4) 4
survival (4) 4
vinblastine - adverse effects (4) 4
vincristine - adverse effects (4) 4
[sdv.can]life sciences [q-bio]/cancer (3) 3
advanced stages (3) 3
antibodies, monoclonal, murine-derived (3) 3
antibodies, monoclonal, murine-derived - therapeutic use (3) 3
antineoplastic agents (3) 3
b-lymphocytes - pathology (3) 3
bleomycin - therapeutic use (3) 3
brief chemotherapy (3) 3
cell survival (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1081 - 1093
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2004, Volume 350, Issue 13, pp. 1287 - 1295
Journal Article
by Horwitz, Steven and O'Connor, Owen A and O'Connor, Owen and Pro, Barbara and Illidge, Tim and Fanale, Michelle and Advani, Ranjana and Bartlett, Nancy and Bartlett, Nancy L and Christensen, Jacob Haaber and Morschhauser, Franck and Domingo-Domenech, Eva and Rossi, Giuseppe and Kim, Won Seog and Feldman, Tatyana and Lennard, Anne and Belada, David and Illés, Árpád and Tobinai, Kensei and Tsukasaki, Kunihiro and Yeh, Su-Peng and Shustov, Andrei and Hüttmann, Andreas and Savage, Kerry and Savage, Kerry J and Yuen, Sam and Iyer, Swaminathan and Zinzani, Pier Luigi and Hua, Zhaowei and Little, Meredith and Rao, Shangbang and Woolery, Joseph and Manley, Thomas and Trümper, Lorenz and Aboulafia, David and Alpdogan, Onder and Ando, Kiyoshi and Arcaini, Luca and Baldini, Luca and Bellam, Naresh and Yehuda, Dina Ben and Benedetti, Fabio and Borchman, Peter and Bordessoule, Dominique and Brice, Pauline and Briones, Javier and Caballero, Dolores and Carella, Angelo Michele and Chang, Hung and Cheong, June Weon and Cho, Seok-Goo and Choi, Ilseung and Choquet, Sylvain and Colita, Andrei and Congui, Angela Giovanna and D'amore, Francesco and Dang, Nam and Davison, Kelly and de Guibert, Sophie and Brown, Peter de Nully and Delwail, Vincent and Demeter, Judit and di Raimondo, Francesco and Do, Young Rok and Domingo, Eva and Douvas, Michael and Dreyling, Martin and Ernst, Thomas and Fay, Keith and Ferrero, Silvia Fernandez and Flinn, Ian Winchester and Forero-Torres, Andres and Fox, Christopher and Friedberg, Jonathan and Fukuhara, Noriko and Garcia-Marco, Jose and Cruz, Jorge Gayoso and Codina, Jose Gomez and Gressin, Remy and Grigg, Andrew and Gurion, Ronit and Haioun, Corinne and Hajek, Roman and Hanel, Mathias and Hatake, Kiyohiko and Hensen, Robert and Horowitz, Netanel and Huttmann, Andreas and Illes, Arpad and Ishizawa, Kenichi and Islas-Ohlmayer, Miguel and Jacobsen, Eric and Janakiram, Murali and Jurczak, Wojciech and Kaminski, Mark and Kato, Koji and Kirgner, Ilya and Kuo, Ching-Yuan and Lazaroiu, Mihaela Cornelia and Du, Katell Le and ... and ECHELON 2 Study Grp and ECHELON-2 Study Group
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 229 - 240
Journal Article
Haematologica, ISSN 0390-6078, 08/2011, Volume 96, Issue 8, pp. 1128 - 1135
Journal Article
Kidney International, ISSN 0085-2538, 07/2019, Volume 96, Issue 1, pp. 94 - 103
The clinicopathological characteristics of kidney infiltration in B-cell lymphoproliferative disorders remain poorly described. We retrospectively studied 52... 
acute kidney injury | kidney biopsy | monoclonal gammopathy | B-cell lymphoma | MULTIPLE-MYELOMA | WORKSHOP | CRITERIA | CLASSIFICATION | FEATURES | UROLOGY & NEPHROLOGY | NON-HODGKINS-LYMPHOMA | CHRONIC LYMPHOCYTIC-LEUKEMIA | CASE SERIES | KIDNEY INVOLVEMENT | Life Sciences
Journal Article
Haematologica, ISSN 0390-6078, 07/2013, Volume 98, Issue 7, pp. 1107 - 1114
Journal Article
Case Reports in Oncology, ISSN 1662-6575, 01/2017, Volume 10, Issue 1, pp. 127 - 129
Autoimmune haemolytic anaemia (AIHA) in mantle cell lymphoma (MCL) is a rare but life-threatening complication. To date, there are no relevant data for... 
Autoimmune hemolytic anaemia | Ibrutinib | Mantle cell lymphoma | Lymphomas | Anemia | Leukemia | Blood tests
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5405 - 5405
Abstract Background. Patients with relapse or refractory (R/R) B-cell Non Hodgkin Lymphoma (B-NHL), especially DLBCL, have a poor prognostic in relation to the... 
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2012, Volume 18, Issue 19, pp. 5203 - 5211
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4231 - 4231
Abstract Background. The Doxorubicin based R-CHOP regimen remains the standard of care for the upfront treatment of DLBCL. The advent of oral idarubicin... 
Journal Article
Hematologie, ISSN 1264-7527, 11/2016, Volume 22, Issue 6, pp. 389 - 391
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2015, Volume 2, Issue 6, pp. e251 - e259
Journal Article
Blood, ISSN 0006-4971, 2012, Volume 119, Issue 16, pp. 3698 - 3704
Journal Article
17.